World Leaders Must Commit More Resources, Take Stronger Actions To End TB Epidemic By 2030
Bloomberg: Who Dies From Tuberculosis?
“Tuberculosis, a disease fueled by poverty, overcrowding, and undernutrition, is a global barometer of deprivation. Of the more than 4,000 men, women, and children TB kills every day, most are poor. … Because healthy people are relatively safe from tuberculosis, improved living standards during the early 20th century helped lower the incidence. … But in recent decades, the emergence of HIV and mutant antibiotic-resistant bacteria have hampered control efforts, slowing the pace of decline in global TB incidence. From 2000 to 2015, TB claimed 33 million lives and cost the world economy an estimated $616 billion, with India, Indonesia, China, and Russia carrying half that burden, according to a recent KPMG report. Unless governments, civil society organizations, and individual citizens take more effective action, by 2030, a further $1 trillion and 28 million lives may be lost” (5/21).
Bloomberg: What It Will Take to Finally Defeat Tuberculosis
“…[W]hen world leaders say they want to end the [TB] epidemic by 2030, they are setting a tight deadline. … [M]edical science needs to come up with quicker, safer, and cheaper ways to diagnose TB, and a pipeline of new drugs to kill the bacteria and its resistant forms. Economic incentives for drug makers are essential … A shortage of global funding for medical research … explains why decades have gone by with no new TB treatments or vaccines. The good news is that a dozen vaccine candidates are now in clinical trials. … But history is clear about the consequences of inaction: Infections will multiply, millions more lives will be lost, and increasing antibiotic resistance will make it even costlier to stop this ancient foe” (5/21).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.